Pfizer's Zoetis sets IPO range

Zoetis Inc. amended its IPO and now plans to sell 86.1 million shares at $22-$25. A $23.50 price would raise $2 billion and value the animal health subsidiary that Pfizer Inc. (NYSE:PFE) is spinning o...